2008: Pediatric Rheumatology: Advances in Therapy
Search or Browse by Day

Pediatric Rheumatology: Advances in Therapy

Monday, October 27, 2008
1244
Long-term Safety And Efficacy Of Tocilizumab In Patients With Systemic Juvenile Idiopathic Arthritis (JIA) Under The Extension And Long-term Trials
1245
A multicentric, double-blind trial of Anakinra versus placebo in Systemic-Onset Juvenile Idiopathic Arthritis (ANAJIS trial): efficacy and tolerance over 12 months
1246
Long-Term Efficacy & Safety Of Infliximab Plus Methotrexate For The Treatment Of Polyarticular Course Juvenile Rheumatoid Arthritis: Findings From An Open-Label Treatment Extension
1247
Mycophenolate Mofetil Compared with Intravenous Cyclophosphamide as Induction Treatment for Pediatric Lupus Nephritis: A Randomized Trial
1248
ACZ885 (Canakinumab), A New IL-1 Beta Blocking Monoclonal Antibody Provides Long-lasting Remission In Children With Cryopyrin Associated Periodic Syndrome (CAPS)
1249
Treatment of Neonatal-Onset Multisystem Inflammatory Disease (NOMID/CINCA) with the IL-1 blocker, anakinra: after 3 years on treatment
See more of: ACR Abstract Submission ACR Concurrent Abstract Session
<< Previous Session Level | Next Session Level >>